Esperion Therapeutics
ESPR
#7554
Rank
HK$2.45 B
Marketcap
HK$12.40
Share price
-4.49%
Change (1 day)
-23.82%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): HK$60.69 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are HK$0.33 Billion. , an increase over its 2023 earnings that were of -HK$1.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 HK$58.33 M-104.99%
2023 -HK$1.17 Billion-15.03%
2022 -HK$1.38 Billion-20.61%
2021 -HK$1.74 Billion84.28%
2020 -HK$0.94 Billion35.75%
2019 -HK$0.7 Billion-55.71%
2018 -HK$1.57 Billion19.57%
2017 -HK$1.31 Billion125.39%
2016 -HK$0.58 Billion51.43%
2015 -HK$0.39 Billion36.45%
2014 -HK$0.29 Billion43.55%
2013 -HK$0.2 Billion145.26%
2012 -HK$79.71 Million
2002 -HK$0.23 Billion-7.81%
2001 -HK$0.25 Billion15.03%
2000 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$3.93 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.21 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$86.36 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$37.14 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.23 Billion-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.56 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA